Thompson JM - Search Results

1

Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine.

Ljungberg K, Whitmore AC, Fluet ME, Moran TP, Shabman RS, Collier ML, Kraus AA, Thompson JM, Montefiori DC, Beard C, Johnston RE. Ljungberg K, et al. Among authors: thompson jm. J Virol. 2007 Dec;81(24):13412-23. doi: 10.1128/JVI.01799-07. Epub 2007 Oct 3. J Virol. 2007. PMID: 17913817 Free PMC article.

2

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

Thompson JM, Whitmore AC, Konopka JL, Collier ML, Richmond EM, Davis NL, Staats HF, Johnston RE. Thompson JM, et al. Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3722-7. doi: 10.1073/pnas.0600287103. Epub 2006 Feb 27. Proc Natl Acad Sci U S A. 2006. PMID: 16505353 Free PMC article.

3

Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen.

Thompson JM, Whitmore AC, Staats HF, Johnston RE. Thompson JM, et al. Vaccine. 2008 Aug 5;26(33):4267-75. doi: 10.1016/j.vaccine.2008.05.046. Epub 2008 Jun 9. Vaccine. 2008. PMID: 18582997 Free PMC article.

4

The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines.

Thompson JM, Whitmore AC, Staats HF, Johnston R. Thompson JM, et al. Vaccine. 2008 Sep 15;26(39):4998-5003. doi: 10.1016/j.vaccine.2008.07.011. Epub 2008 Jul 24. Vaccine. 2008. PMID: 18656518 Free PMC article.

5

Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.

LoBue AD, Thompson JM, Lindesmith L, Johnston RE, Baric RS. LoBue AD, et al. Among authors: thompson jm. J Virol. 2009 Apr;83(7):3212-27. doi: 10.1128/JVI.01650-08. Epub 2009 Jan 28. J Virol. 2009. PMID: 19176631 Free PMC article.

6

Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge.

Konopka JL, Thompson JM, Whitmore AC, Webb DL, Johnston RE. Konopka JL, et al. Among authors: thompson jm. J Virol. 2009 Dec;83(23):12432-42. doi: 10.1128/JVI.00564-09. Epub 2009 Sep 30. J Virol. 2009. PMID: 19793821 Free PMC article.

7

An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.

Heise MT, Whitmore A, Thompson J, Parsons M, Grobbelaar AA, Kemp A, Paweska JT, Madric K, White LJ, Swanepoel R, Burt FJ. Heise MT, et al. Epidemiol Infect. 2009 Sep;137(9):1309-18. doi: 10.1017/S0950268808001696. Epub 2009 Jan 27. Epidemiol Infect. 2009. PMID: 19171081 Free article.

8

A two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo.

Konopka JL, Penalva LO, Thompson JM, White LJ, Beard CW, Keene JD, Johnston RE. Konopka JL, et al. Among authors: thompson jm. PLoS Pathog. 2007 Dec;3(12):e199. doi: 10.1371/journal.ppat.0030199. PLoS Pathog. 2007. PMID: 18215114 Free PMC article.

9

Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node.

Thompson JM, Nicholson MG, Whitmore AC, Zamora M, West A, Iwasaki A, Staats HF, Johnston RE. Thompson JM, et al. J Immunol. 2008 Jul 1;181(1):574-85. doi: 10.4049/jimmunol.181.1.574. J Immunol. 2008. PMID: 18566424 Free PMC article.

10

Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains.

LoBue AD, Lindesmith L, Yount B, Harrington PR, Thompson JM, Johnston RE, Moe CL, Baric RS. LoBue AD, et al. Among authors: thompson jm. Vaccine. 2006 Jun 12;24(24):5220-34. doi: 10.1016/j.vaccine.2006.03.080. Epub 2006 Apr 18. Vaccine. 2006. PMID: 16650512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

982 results

Search Page

Filters